This study identifies distinct lesion features in MCL and underscores secondary infection as a key modifiable factor associated with prolonged therapy. These findings support the need for early recognition, infection control, and tailored clinical strategies to improve leishmaniasis outcomes in endemic settings.
Esen et al. (Wed,) studied this question.